Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine (Review)

Zhang,Chen; Xu,Xia

doi:10.3892/etm.2016.3025

Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine (Review)

Authors:
- Chen Zhang
- Xia Xu
View Affiliations

Affiliations: Nanjing University of Chinese Medicine, Nanjing 210000, P.R. China, Xuzhou City Hospital of Traditional Chinese Medicine, Xuzhou, Jiangsu 221000, P.R. China
Published online on: January 26, 2016 https://doi.org/10.3892/etm.2016.3025
Pages: 1173-1176
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diminished ovarian reserve (DOR) refers to the decreased production of mature ova in ovarium and decreased quality of oocyte, leading to deficiency of the female sex hormone and decreased fertility. DOR can also develop into premature ovarian failure, which affects female life quality and constitutes an important cause of female infertility. A fast lifestyle, environmental deterioration and accumulated understanding of this disease, have led to an increase in the incidence of DOR. Therefore, reasonable and effective treatment for DOR is particularly important to improve ovarian function and female life quality as well as reduce infertility. This mini review provides recent updates regarding DOR and a summary of advancements in the treatment of DOR using Chinese and Western Medicine.

View Figures

View References

1	Cao Z-Y: Obstetrics and Gynaecology (2nd). Beijing: People's Medical Publishing House. 2004.(In Chinese).
2	Zhu L, Chen CX and Yin WW: A study on the pathogenesis of 72 patients with diminished ovarian reserve. Chin J Tradit Chin Med. 11:1233–1234. 2012.(In Chinese).
3	Xu X and Tan Y: Treatment of diminished ovarian reserve by Traditional Chinese Medicine syndrome differentiation. Univ Tradit Chin Med. 3:325–327. 2010.(In Chinese).
4	Tang WL, Hu YH and He XH: Research progress of traditional Chinese medicine and Western Medicine on the decline of ovarian reserve. J Shanxi Med. 15:1797–1799. 2014.(In Chinese).
5	Hang Y: The experience of He Jialin in the treatment of decreased ovarian reserve. Proc Zhejiang Univ Tradit Chin Med. 38:1064–1065. 2014.(In Chinese).
6	Li X: Clinical application of TCM approaches in delayed menorrhea (Diminished ovarian reserve). Chengdu Univ Tradit Chin Med. 2014.(In Chinese).
7	Shi Y, Yang S and Tao L: Clinical observation of Zishen Butai pill in the treatment of diminished ovarian reserve with weak spleen and kidney. Proc Shandong Univ Tradit Chin Med. 37:292–294. 2013.
8	Meng X and Fan Y: Clinical observation of the pre-treatment in 98 infertile DOR patients. Matern Child Health Care China. 27:2973–2975. 2012.
9	Zhang J: Clinical study of Black turtle in the treatment of diminished ovarian reserve. Nanjing Univ Chin Med. 2013.(In Chinese).
10	Huang X, Liang S and Lu W: Clinical observation of tonifying kidney and regulating menstruation combined with Western medicine in the treatment of DOR. Chin J Integr Med. 34:688–690. 2014.(In Chinese).
11	Meng Q, Fu Y and Cao B: The effect of TCM periodic treatment on ovarian reserve. J Tradit Chin Med. 31:644–645. 2011.(In Chinese).
12	Ruan H: Clinical observation of TCM periodic treatment in DOR patients. Guangzhou Univ Chin Med. 2011.(In Chinese).
13	Zhang Y, Fang Y and Li L: Clinical observation of the effect of acupuncture and drugs on ovarian reserve. Sichuan Tradit Chin Med. 28:103–104. 2010.(In Chinese).
14	Zhang M: Clinical observation of Zuigui pill and auricular plaster in the treatment of DOR patients with deficiency of kidney-Yin. Guangzhou Univ Chin Med. 2012.
15	Li Y and Chen C: Clinical observation of sequential therapy with estrogen and progestogen in the treatment of diminished ovarian reserve. Guide Chin Med. 10:113–114. 2012.(In Chinese).
16	Qian Q, Sun L and Wang X: The effect of oral contraceptives in the short-term ovulation induction by IVF-ET. Chin J Birth Health Hered. 19:102–104. 2011.
17	Nielsen ME, Rasmussen IA, Kristensen SG, Christensen ST, Møllgård K, Andersen Wreford E, Byskov AG and Andersen Yding C: In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Mol Hum Reprod. 17:63–70. 2011.(In Chinese). View Article : Google Scholar : PubMed/NCBI
18	Zhang D: Clinical effect of dehydroepiandrosterone in diminished ovarian reserve. Union School Clin Med. 2013.
19	Rugh R: Induced ovulation and artificial fertilization inthe frog. Biolog Bull. 66:22–23. 1934. View Article : Google Scholar
20	Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW and Broekmans FJ: AMH and AFC as predictors of excessive response in controlledovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 17:46–54. 2010. View Article : Google Scholar : PubMed/NCBI
21	Revelli A, Casano S, Salvagno F and Delle Piane L: Milder is better? Advantages and disadvantages of ‘mild’ ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol. 9:252011.(In Chinese). View Article : Google Scholar : PubMed/NCBI
22	Geng JX, Zhang SD and Zhang CL: Application of different ovulation induction programs in patients with low ovarian response. Reprod Contracept. 30:837–840. 2010.
23	Sauer MV: Ethics and reproductive medicine. Preface. Semin Reprod Med. 28:277–280. 2010. View Article : Google Scholar : PubMed/NCBI
24	Peng N, Yuan A and Zou H: Ovary transplantation and its applications. Adv Vet Med. 32:99–103. 2011.
25	Zhang L, Zhao F and Wang G: The efficacy of Integrative Medicine in the treatment of infertile DOR patients. Matern Child Health Care China. 26:4293–4295. 2014.
26	Liu L: Clinical observation of nourishing kidney decoction and Western medicine in the treatment of oligomenorrhea due to DOR. Heilongjiang Univ Tradit Chin Med. 2012.
27	Zhang T and Li S: Observation of 46 infertile DOR patients receiving pre-treatment. Clin Med (Northfield IL). 30:78–79. 2010.